Neurobiology of Opioid Dependence: 2 - 2

Yale University logo

Yale University

Status and phase

Withdrawn
Phase 2

Conditions

Opioid-Related Disorders

Treatments

Drug: Gamma hydroxybutyric

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000193
K20-00191-2
NIDA-00191-2
K20DA000191 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems